Sign in to view content

Efficacy, Safety, and Durability of Faricimab in Diabetic Macular Edema (DME): One-Year Results From the Phase 3 YOSEMITE and RHINE Trials

Caroline Baumal, MD

Video
Published 2021

Related

Diabetic Retinopathy 1 Symposium
Annual Meeting Talks
2020
New Data and Insights from Several DRCR.net Protocols
Lee Jampol, MD
Updates from the Field
2017
Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)
Dante Joseph Pieramici, MD
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more